Disclosure of the 2026 first-quarter earnings overview and HIV business status. Highlights include trends in sales, operating income, and quarterly results, with emphasis on domestic and international sales composition and contributions by specific segments (LAVI, HIV-related products, etc.). Also explains developments in new products and pipeline.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4507","jir_company_name":"Shionogi & Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-03","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4507-20260803-03.pdf","jir_short_summary":"Disclosure of the 2026 first-quarter earnings overview and HIV business status. Highlights include trends in sales, operating income, and quarterly results, with emphasis on domestic and international sales composition and contributions by specific segments (LAVI, HIV-related products, etc.). Also explains developments in new products and pipeline.","jir_summary":"### Overview of Results\nThis quarter\u2019s financial disclosures focus on presenting revenue and profit levels. Explanations of contributions by major segments, domestic and international sales mix, and product-level contributions are provided with charts. Progress on new products and the pipeline is also shown, with HIV-related products expected to be growth drivers and contributions from overseas markets in the future.\n\n### Outlook and Strategy\nBased on first-quarter results, measures to sustain revenue growth include expanding the HIV franchise, acquiring new customers in the United States, and optimizing R&D investment. In the long term, the policy is to strengthen the development pipeline and promote global expansion.","jir_financial_highlights":"Sales: Unknown (Unknown)\nOperating income: Unknown (Unknown)\nPre-tax quarterly income: Unknown (Unknown)\nEBITDA: Unknown (Unknown)","jir_category":"","jir_hashtags":"#Shionogi, #financial_summary, #JapanStocks","jir_key_figures":"Sales: Unknown (not listed in PDF)\nOperating income: Unknown (not listed in PDF)\nEBITDA: Unknown (not listed in PDF)","jir_meta_title":"[Shionogi] 2026 First Quarter Results Overview and HIV Business Update | 2026-08-03","jir_meta_description":"An overview of Shionogi\u2019s 2026 first-quarter results and HIV business developments. Summarizes sales and profit trends, segment contributions, and future growth strategies and pipeline progress for investors.","jir_og_title":"Shionogi's Q1 Results and HIV Business Update","jir_og_description":"Overview of Shionogi\u2019s 2026 fiscal year Q1 results and latest HIV business developments. Summaries contributions by segment and future growth strategy.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[]","ir_related_company":6919,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-93450","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n